Bay Area's Pionyr Immunotherapeutics Scores $62M to Push Anti-Tumor Tech Towards Clinic Post author:Sam Post published:December 12, 2017 Post category:BioPharma Pionyr was founded in 2015 by a UCSF professor and a Genentech alum. Source: BioSpace You Might Also Like Former Sarepta CEO Emerges to Helm Newly-Launched $25 Million Biotech Startup Accelerator May 17, 2017 5 Startups to Watch Out For August 22, 2017 Elekta Radiosurgery Solutions Highlighted At May 25, 2017
Former Sarepta CEO Emerges to Helm Newly-Launched $25 Million Biotech Startup Accelerator May 17, 2017
